
Search
Selected Filter
Filter Results
Displaying 51–60 of 285 research results
-
Sep 27, 2021
Foundation Awarded 21 New Grants in FY2021 Totaling More than $14.2 Million
Current research portfolio is comprised of nearly 100 projects at prominent institutions around the world
-
Sep 24, 2021
MeiraGTx and Janssen Recruiting for Phase 3 XLRP Gene Therapy Clinical Trial
Visit www.LUMEOSstudy.com for more information about trial
-
Sep 10, 2021
Apellis to Seek FDA Approval of its Dry AMD Drug
Known as APL-2, the drug met its primary endpoint in the OAKS clinical trial but not the DERBY trial
-
Sep 9, 2021
Optogenetics: Hope for Vision Restoration for Advanced Retinal Diseases
Early, encouraging results from two human studies — trials launched by Bionic Sight and GenSight — are putting optogenetic therapies in the spotlight for patients with advanced vision loss from retinal conditions.
-
Jul 19, 2021
Nanoscope Therapeutics Launches Phase 2b Clinical Trial for Optogenetic Therapy
While the trial is for people with RP, the company hopes it will also benefit people with other retinal degenerative diseases
-
Jun 25, 2021
The company is planning a late-stage trial for its achromatopsia (CNGB3) gene therapy.
-
Jun 15, 2021
Biogen’s Phase 3 Clinical Trial for its Choroideremia Gene Therapy Doesn’t Meet Endpoints
Additional results from the trial will be reported at a future scientific meeting
-
May 24, 2021
Investigators Report Partial Vision Restoration for One Patient in Optogenetic Therapy Trial
The gene-agnostic approach is designed to restore some vision to people with advanced vision loss
-
May 14, 2021
Biogen’s Phase 2/3 Clinical Trial for XLRP Gene Therapy Doesn’t Meet Primary Endpoint
More details from the clinical trial will be reported at a later date
-
May 10, 2021
AGTC Continues to Report Encouraging Data from its Phase 1/2 XLRP Gene Therapy Clinical Trial
The company is planning the launch of a Phase 2/3 trial for its XLRP gene therapy